L. Carter Bruce

Insider Reports History

Entity
Individual
Location
C/O Zymogenetics, Inc., 1201 Eastlake Avenue, Seattle, Washington
Signature
/s/ Paul J. Mellett as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by L. Carter Bruce:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ENANTA PHARMACEUTICALS INC Director Stock Option (right to buy) 15.7K Mar 6, 2024 Direct
ALSP Orchid Acquisition Corp I Director No securities are beneficially owned 0 Nov 18, 2021 Direct
Mirati Therapeutics, Inc. Director Common Stock 0 $59.02 Jan 23, 2024 Direct
Mirati Therapeutics, Inc. Director Option to Purchase Common Stock 0 Jan 23, 2024 Direct

Insider Reports Filed by L. Carter Bruce

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENTA ENANTA PHARMACEUTICALS INC Mar 6, 2024 1 $0 4 Mar 8, 2024 Director
MRTX Mirati Therapeutics, Inc. Jan 23, 2024 6 $0 4 Jan 23, 2024 Director
MRTX Mirati Therapeutics, Inc. Dec 29, 2023 1 $400K 4 Jan 3, 2024 Director
ENTA ENANTA PHARMACEUTICALS INC Mar 2, 2023 1 $0 4 Mar 6, 2023 Director
MRTX Mirati Therapeutics, Inc. Jan 20, 2023 2 $0 4 Jan 24, 2023 Director
MRTX Mirati Therapeutics, Inc. Aug 12, 2022 4 -$585K 4 Aug 16, 2022 Director
ENTA ENANTA PHARMACEUTICALS INC Mar 21, 2022 6 -$253K 4 Mar 22, 2022 Director
ENTA ENANTA PHARMACEUTICALS INC Mar 3, 2022 1 $0 4 Mar 7, 2022 Director
MRTX Mirati Therapeutics, Inc. Jan 14, 2022 2 $0 4 Jan 18, 2022 Director
ALOR ALSP Orchid Acquisition Corp I Nov 18, 2021 0 $0 3 Nov 18, 2021 Director